MedTrace Logo

Pharmacokinetics of Antibiotics During Extracorporeal Membrane Oxygenation (ECMO) Support

NCT03922451 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2022-03-21

No results posted yet for this study

Summary

This study will measure plasma concentrations of piperacillin-tazobactam and cefazolin in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to better understand the pharmacokinetics of these medications in this in vivo setting.

Conditions

  • Drug Effect

Interventions

DRUG

piperacillin-tazobactam

Administered for infection treatment or prophylaxis per hospital protocol

DRUG

Cefazolin

Administered for infection treatment or prophylaxis per hospital protocol

Sponsors & Collaborators

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-27
Primary Completion
2020-04-01
Completion
2022-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03922451 on ClinicalTrials.gov